Prototek is a producer of small molecule inhibitor therapeutics for pneumocystis pneumonia. The firm is an emerging biotechnology company focused on the deployment of proprietary inhibitor compounds for treatment of AIDS dementia, myasthenia gravis, Alzheimerí=s disease, Huntingtons disease and other neurodegenerative diseases.
